Appeals Court Overturns Defense Verdict from First Taxotere Hair Loss Bellwether Trial
A federal appeals court has overturned a defense verdict in the first Taxotere hair loss bellwether trial, calling for a new trial to be held.
A federal appeals court has overturned a defense verdict in the first Taxotere hair loss bellwether trial, calling for a new trial to be held.
Sanofi faces several new lawsuits claiming Taxotere eye problems resulted in vision damage and vision loss, which may be folded together into a new MDL for the breast cancer drug.
A second Taxotere bellwether trial over permanent hair loss has resulted in a defense verdict.
A class action lawsuit claims Johnson & Johnson falsely advertises OGX shampoo and conditioner products as safe, despite containing chemicals which could cause hair loss, skin irritation and cancer.
A class action lawsuit claims Unilever purposefully mislead consumers about formaldehyde in suave hair care products, resulting in hair loss, allergic reactions and an increased risk of cancer.
Three Taxotere hair loss lawsuits have been selected to serve as potential fourth bellwether trials over claims the chemotherapy drug's manufacturers failed to warn patients of the risk of permanent…
A federal judge, after denying a flurry of summary judgment requests, has delayed the next Taxotere hair loss bellwether lawsuit, which was slated to go to trial in February.
A federal judge has dismissed nearly 200 Taxotere lawsuits for being filed after the manufacturer added a warning to the label about permanent hair loss risks, but indicated the bulk…
Four bellwether trials over Taxotere hair loss claims will be held over the next two years, a federal judge has ordered.
Three claims have been chosen to serve as potential Taxotere bellwether trial cases in August 2020.